Efficacy and Safety of Hemp-derived, Full Spectrum Cannabigerol (CBG) in Adults

Clinical trial NCT05743985 · COMPLETED

Trial details

NCT number: NCT05743985
Sponsor: Formula30A LLC
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Health, Subjective Inflammatory Response Adverse Effect Side Effect

Start date: 2022-08-01
Primary completion: 2023-12-31
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.